Patents by Inventor Dong Sup Shim

Dong Sup Shim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanocortin receptor agonists
    Patent number: 8288386
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: October 16, 2012
    Assignee: LG Life Sciences Ltd.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • Melanocortin receptor agonists
    Patent number: 8236955
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: August 7, 2012
    Assignee: LG Life Sciences Ltd.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • Melanocortin receptor agonists
    Patent number: 8183243
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: May 22, 2012
    Assignee: LG Life Sciences Ltd.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • Melanocortin receptor agonists
    Patent number: 8039622
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: October 18, 2011
    Assignee: LG Life Sciences Ltd.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, Dong Sup Shim, Soo Yong Chung
  • MELANOCORTIN RECEPTOR AGONISTS
    Publication number: 20110245500
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Application
    Filed: June 13, 2011
    Publication date: October 6, 2011
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • MELANOCORTIN RECEPTOR AGONISTS
    Publication number: 20110237795
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Application
    Filed: June 13, 2011
    Publication date: September 29, 2011
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • MELANOCORTIN RECEPTOR AGONISTS
    Publication number: 20110224219
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Application
    Filed: November 10, 2009
    Publication date: September 15, 2011
    Applicant: LG LIFE SCIENCES LTD.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • Melanocortin receptor agonists
    Patent number: 7989634
    Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: August 2, 2011
    Assignees: LG Life Sciences Ltd., Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Koo Lee, Heui-Sul Park, In-Ae Ahn, Hyun-Ju Yoo, Jong-Yup Kim, Deog-Young Choi, Hyeon-Joo Yim, Kyung-Ha Chung, Dong-Sup Shim, Sang-Kyun Lee, Yutaka Kondoh, Ryoji Hirabayashi, Shugo Honda, Hidetaka Kaku, Jun-ichi Shishikura, Hiroyuki Ito, Takeshi Kurama
  • Melanocortin receptor agonists
    Patent number: 7879852
    Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: February 1, 2011
    Assignee: LG Life Sciences Ltd.
    Inventors: Sung Pil Choi, In Ae Ahn, Sang Hyup Lee, Sang Dae Lee, Mi Sook Shin, Koo Lee, Deog Young Choi, Dong Sup Shim, Hyeon Joo Yim, Min Kyung Yoon, Soo Yong Chung, Jung Ae Lee, Yong Hwa Ha, Young Kwan Kim, Oeuk Park, Hyun Min Lee, Youn Hoa Kim
  • MELANOCORTIN RECEPTOR AGONISTS
    Publication number: 20100120783
    Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
    Type: Application
    Filed: November 10, 2009
    Publication date: May 13, 2010
    Applicant: LG LIFE SCIENCE LTD.
    Inventors: Koo Lee, Sang Dae Lee, Sang Pil Moon, In Ae Ahn, Sung Pil Choi, Hyun Ho Lee, Dong Sup Shim, Soo Yong Chung, Hyun Min Lee
  • MELANOCORTIN RECEPTOR AGONISTS
    Publication number: 20090298829
    Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Application
    Filed: July 13, 2007
    Publication date: December 3, 2009
    Inventors: Sung Pil Choi, In Ae Ahn, Sang Hyup Lee, Sang Dae Lee, Mi Sook Shin, Koo Lee, Deog Young Choi, Dong Sup Shim, Hyeon Joo Yim, Min Kyung Yoon, Soo Yong Chung, Jung Ae Lee, Yong Hwa Ha, Young Kwan Kim, Oeuk Park, Hyun Min Lee, Youn Hoa Kim
  • Melanocortin receptor agonists
    Publication number: 20070129346
    Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
    Type: Application
    Filed: November 12, 2004
    Publication date: June 7, 2007
    Applicants: LG Life Sciences Ltd., Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Koo Lee, Heui-Sul Park, In-Ae Ahn, Hyun-Ju Yoo, Jong-Yup Kim, Deog-Young Choi, Hyeon-Joo Yim, Kyung-Ha Chung, Dong-Sup Shim, Sang-Kyun Lee, Yutaka Kondoh, Ryoji Hirabayashi, Shugo Honda, Hidetaka Kaku, Jun-ichi Shishikura, Hiroyuki Ito, Takeshi Kurama
  • Humanized antibodies LB-00503 and LB-00506 specific for human 4-1BB and pharmaceutical compositions comprising said humanized antibodies
    Publication number: 20030096976
    Abstract: The present invention relates to humanized monoclonal antibodies LB-00503 and LB-00506, which are specific for human 4-1BB molecules, have high binding affinities and can bind efficiently with activated T cells expressing the 4-1BB molecule, as well as pharmaceutical compositions. Particularly, the present invention provides said humanized antibody LB-00503, which is modified from the humanized antibody Hz4B4-2 and substitutes the 61st amino acid, serine by asparagine in the amino acid residues of 59th˜61st and said humanized antibody LB-00506, which enhances the antibody binding affinity of said humanized antibody LB-00503 in which 2 amino acid residues of the right border in the antibody binding site CDR2 of the heavy chain variable region are substituted from glutamine (Q)—glycine (G) to lysine (K)—serine (S).
    Type: Application
    Filed: September 4, 2002
    Publication date: May 22, 2003
    Inventors: Hyo Jeong Hong, Sung Sup Park, Young Jun Kang, Chang-Yuil Kang, Sung Kwan Yoon, Youngwoo Park, Hyesung Yoon, Hyunsook Jang, Geun Bae Rha, Jin-San Yoo, Jong Keun Jeong, Dong Sup Shim, Mijeong Park, Hwadong Kim, Jung-Gyu Park, Jae-Young Yang